Background. Life expectancy of people with intellectual disabilities (IDs) is rapidly normalizing, as are prevalences of age-related cardiovascular disease in this group. We investigated the prevalence of the metabolic syndrome in the older population with ID and associations with patient characteristics. Methods. Prevalence of the metabolic syndrome, according to National Cholesterol Education Program-Adult Treatment Panel III criteria, was assessed with standardized physical examinations in 470 Dutch adults with ID, aged >50 years, who receive residential care from three Dutch care providing organizations. Because of skewing towards an overrepresentation of females and more moderate to severe ID in the study population, reweighting was applied to obtain a representative population prevalence. Correlations with patient characteristics were analysed with logistic regression analyses. Results. Four hundred and twelve participants completed all assessments. The weighted prevalence of the metabolic syndrome was 25.1% [95% confidence interval (CI) 21.0-29.3%], with a significantly higher risk for people with mild ID.
Introduction
Life expectancy of people with intellectual disabilities (IDs) is rapidly normalizing, as is prevalence of agerelated cardiovascular disease (CVD) in this group. Several authors have highlighted the unhealthy lifestyle of people with ID, specifically in the growing group of adults with mild or moderate ID living independently or in community-based settings. 1 Although a high prevalence of obesity and other health problems is well established, 2 the substantial prevalence of CVD 3 hardly receives any attention. The metabolic syndrome, as defined by the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III), 4 is associated with an increased risk of CVD and type 2 diabetes. 5 Indeed, an association between lack of exercise and high dietary fat intake and two components of the metabolic syndrome, abdominal obesity and hyperinsulinemia, has been established in adults with ID. 6 We studied the prevalence of the metabolic syndrome in the older population with ID and its association with patient characteristics (age, sex, severity of ID, Down syndrome, lack of exercise, smoking and use of atypical antipsychotic drugs).
Methods
The present cross-sectional evaluation was conducted as part of a screening programme for cardiovascular risk factors among older adults with ID. 7 All residential clients of three care providing agencies, who were aged >50 years and received primary health care by specialized ID physicians, were invited to participate. A power analysis showed that, allowing a margin of error of 5% and a confidence level (CI) of 95%, at least 369 individuals needed to be included, in order to find a prevalence rate of obesity of 40%, as has been reported in women residing in group homes. 8 Informed consent for participation was obtained from all eligible clients. If clients were not able to make decisions on this matter, their legal representatives were asked to give informed consent. The study was approved by the local ethics committees and the boards of management of the three participating organizations in the north and centre of the Netherlands.
The metabolic syndrome was defined, according to NCEP-ATP III criteria, as the presence of at least three of the following five symptoms: abdominal obesity (waist circumference for men >102 cm and women >88 cm), insulin resistance (serum fasting glucose >110 mg/dl or >6.1 mmol/l), hypertriglyceridemia (>150 mg/dl or >1.7 mmol/l), low high-density lipoprotein (HDL) cholesterol (<40 mg/dl or <1.0 mmol/l in men and <50 mg/dl or <1.3 mmol/l in women) and hypertension (blood pressure systolic >130 mmHg and diastolic >85 mmHg). 4 Waist circumference and systolic blood pressure were measured by physical examination. In blood samples, obtained after an overnight fast, levels of glucose, triglycerides and high-density lipoprotein (HDL) cholesterol were assessed.
Patient characteristics (age, gender, Down syndrome and use of atypical antipsychotics) were collected from the medical charts. Each participant had formerly been tested on intellectual functioning by psychologists working for the care providers. Severity of ID was classified as mild [intelligence quotient (IQ) 50-69], moderate (ID 35-49), severe (IQ 20-34) and profound (IQ <20). 9 In a semistructured interview, participants or a responsible caretaker were asked for the level of daily exercise and smoking habits. Lack of exercise was defined according to World Health Organization criteria as <30 minutes moderate exercise during at least 5 days a week 10 and smoking as a minimum use of one cigarette, cigar or pipe a week.
Data were analysed using SPSS version 14.0. We expected the sample not to be representative for the total older population with ID in the Netherlands because it was recruited among those receiving specialized primary medical care by ID physicians, including relatively many persons with more severe levels of ID. Furthermore, females were expected to be overrepresented due to one setting being a former nunnery, exclusively offering care to female clients. Therefore, based on published information on the composition of the Dutch population with ID, 11 a weighted prevalence was computed 12 for all eight combinations of level of ID (mild/moderate/severe/profound) and sex.
To evaluate associations between the weighted prevalence of metabolic syndrome and patient characteristics (age, linear in years, sex, level of ID, Down syndrome, lack of exercise, smoking and use of atypical antipsychotics), firstly, univariate regression analyses were performed with each of the variables. Variables which were associated at P < 0.2 were included in a subsequent multiple logistic regression analysis.
Results
Of the 1781 clients from the three organizations, 478 participants aged >50 years received primary health care from ID physicians. They all consented for screening on cardiovascular risk factors. Eight participants or legal representatives consented to participate in the screening but did not give consent for publication. The remaining 470 clients with moderate to severe ID were included for the present study. Mean age was 61.0 years (range 50-90). A total of 72.8% were female and most participants had moderate (33.2%) or severe (34.3%) ID. A total of 12.1% had mild ID and 20.4% had profound ID. A total of 11.5% had Down syndrome. All assessments needed for classification according to NCEP-ATP III criteria were completed by 412 participants. There were no significant demographic differences between participants and non-participants. Ninety-nine of these 412 participants met the criteria for the metabolic syndrome (24.0%). The weighted prevalence was 25.1% (95% CI 21.0-29.3%). The prevalence of the metabolic syndrome and it's components in relation to patient characteristics is shown in Table 1 .
In the univariate regression analysis, only age and level of ID appeared relevant variables for metabolic syndrome (P < 0.2). No association was found with gender, Down syndrome, lack of exercise, smoking and atypical antipsychotic medication (but only five people used such medication) ( Table 2 ). The subsequent multiple logistic regression analysis showed that persons with moderate (P = 0.001) or severe ID (P = 0.001) had a significantly lower risk of developing the metabolic syndrome than people with mild ID. No association was found with age (Table 3 ).
Discussion
This study shows that the prevalence of metabolic syndrome at age >50 years is significantly higher in this group of people with ID (25.1%, 95% CI 21.0-29.3%) than in the general Dutch population of the same age (15.7%, 95% CI 13.5-17.9%). 13 Those with mild ID have a significantly higher risk than people with moderate or severe ID, supporting the suggestion of a relationship with more independent living. No associations were found with smoking and lack of exercise.
Limitations were some of the study population characteristics. Unfortunately, as a result of one of the participating care organizations being a former nunnery and the exclusion of clients receiving medical care by Family Practice-an international journal GPs, the study population was skewed towards an overrepresentation of females and more severe ID. Therefore, the found prevalence was not directly representative for the total population of ageing people with ID. Nevertheless, the study population and subgroups were large enough to apply computation of weighted prevalence, compensating for any bias in the prevalence due to unequal distribution in sex or level of ID, in order to obtain a valid population prevalence with a relatively narrow CI. However, main strengths of the present study were the large study group and the high level of participation. Therefore, our findings, indicating a major health risk for this vulnerable group, are a cause of serious concern. It is not to be expected that ID in itself makes these persons more prone to age-related CVD. Therefore, the very high prevalence of the metabolic syndrome must reflect an unhealthy lifestyle and low detection and treatment of 'regular' health problems. 14 In our view, healthy behaviour should be stimulated, especially in the relatively large group with milder levels of ID. It is to be expected that a specific approach is needed to get these people interested and motivated to change their lifestyle. Therefore, the development of specific programmes, based on careful qualitative research in this group, should become a high priority among health care researchers and funding agencies in high-income countries.
Furthermore, secondary prevention through timely detection and treatment of cardiovascular risk factors will require proactive screening in this group because in our practical experience, adults with ID usually are not very concerned as long as they do not experience alarming disease symptoms.
We conclude that specific efforts are required to diminish health inequality of this subpopulation in the field of age-related CVD. Active screening of risk factors over age 50 years should be encouraged by guidelines for GPs and physicians working for this group. Furthermore, specific research is needed into personal and environmental factors hampering or advancing healthy behaviour by adults with ID, as well as evaluation of health programmes based on this knowledge. 
